Akeso Secures $250 Million USD to Propel Global Expansion of Its Innovative Drug Pipeline
- Written by PR Newswire
Expediting International Clinical Trials for Pivotal Products
Key Participants Include International Long-Term and Healthcare Funds
HONG KONG, Oct. 13, 2024 /PRNewswire/ -- Akeso Biopharma (9926. HK) ("Akeso", the "Company" ) announced that it has successfully raised approximately $250 million USD through a share placement. This offering has...
Read more: Akeso Secures $250 Million USD to Propel Global Expansion of Its Innovative Drug Pipeline














